Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Rhinomed Limited
  6. Company
    RNO   AU000000RNO1

RHINOMED LIMITED

(RNO)
SummaryQuotesChartsNewsCalendarCompanyFinancials 
Business Summary
Rhinomed Limited is an Australia-based medical technology company that enhancing respiration, sleep, diagnosis of upper respiratory disease, and nasal drug delivery. The CompanyÔÇÖs products include Mute, Turbine, Pronto Sleep, and Pronto Clear. The Mute is a nasal technology that is designed to allow the user to manage the sleep by breathing more and snoring less. The Turbine is a nasal dilator designed to assist the user to breathe during aerobic exercise. Pronto Sleep, which combines the benefits of a nasal dilator, to open the nose and improve airflow, with the soothing vapors of four pure essential oils. Pronto Clear, which combines the benefits of a nasal dilator, to open the nose and improve airflow, with the ability to deliver the vapors of six pure essential oils traditionally known to clear a stuffy nose naturally. Its products, including Turbine and Mute, are sold online and through pharmacies, sleep clinics, and sports stores.
Sales per Business
20202021Delta
Nasal Stent Delivery Technologies3.57100%3.89100% +9.24%
AUD in Million
Sales per region
20202021Delta
Australia3.57100%3.89100% +9.24%
AUD in Million
Managers
Name Title Age Since
Michael Johnson Chief Executive Officer, MD & Executive Director - 2015
Sean Slattery Chief Financial Officer & Secretary - 2020
Brent J. Scrimshaw Independent Non-Executive Director - 2015
Eric Knight Independent Non-Executive Director - 2015
Members of the board
Name Title Age Since
Ronald Dewhurst Non-Executive Chairman 68 2015
Michael Johnson Chief Executive Officer, MD & Executive Director - 2015
Brent J. Scrimshaw Independent Non-Executive Director - 2015
Eric Knight Independent Non-Executive Director - 2015
John McBain, Dr. Non-Executive Director - 2021
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 253,809,132 79,557,974 31.3% 0 0.0% 31.3%
Shareholders
NameEquities%
John McBain 44,779,276 17.2%
Ronald Dewhurst 13,250,000 5.10%
Mutual Trust Pty Ltd. 3,000,000 1.15%
Kensington Capital Management Pty Ltd. 2,800,000 1.08%
Ken Siebel 1,249,929 0.48%
Jasforce Pty Ltd. 1,158,009 0.45%
Netwealth Investments Ltd. 1,128,578 0.43%
Mhbiat Pty Ltd. 1,000,000 0.38%
Phillip Keith Biggs 1,000,000 0.38%
Opima Pty Ltd. 1,000,000 0.38%
Brand Portfolio
In partnership withAllbrands.markets
More brands of Rhinomed Limited